财经快讯|辰欣药业:第二大股东北海辰昕拟减持不超1%公司股份
辰欣药业5月9日公告,自公告披露之日起满15个交易日后的3个月内,北海辰昕拟通过集中竞价交易方式合计减持数量不超过452.77万股,不超过公司总股本的1%。
截至本次减持计划披露之日,公司第二大股东北海辰昕持有公司无限售流通股份4678.2万股,占辰欣药业总股本的10.33%。
Statement:
The content of this article does not represent the views of fxgecko website. The content is for reference only and does not constitute investment suggestions. Investment is risky, so you should be careful in your choice! If it involves content, copyright and other issues, please contact us and we will make adjustments at the first time!